The Australian Bragg Centre is a $500 million addition to the largest health and biomedical precinct in the Southern Hemisphere, Adelaide’s BioMed City that will have the potential to change lives for thousands of cancer patients across the country.
This unique piece of infrastructure will be home to the first proton therapy centre in Australia, The Australian Bragg Centre for Proton Therapy and Research, delivering the most technologically advanced precision radiation therapy to people who would normally travel overseas for their treatment.
Once complete, it will also incorporate world-class facilities for cutting edge research by SAHMRI and lab and office space for SA Health and biomedical companies keen to be part of Adelaide’s burgeoning biomed industry and educational institutions.
The Australian Bragg Centre has been made possible through an innovative partnership between the private sector and Federal and State governments. South Australia’s leading developer Commercial & General has been a driving force behind the project in collaboration with SAHMRI, designing, funding and developing the business case.
Construction on the 15-storey premises is now underway and will support 1,000 jobs and generate an estimated $1 billion in economic activity during construction. Practical completion is anticipated in Q3 2023 with the first patients expected to be treated approximately 18 months later.